Officers

Chairman of the Board of Directors

Phil Dawson, Ph.D.
Professor and Chair, Department of Chemistry, Scripps Research

President of the Foundation

Adam Mezo, Ph.D.

Vice President, Research, Peptides and Bioconjugates, Neurocrine Biosciences, Inc.

Dr. Adam Mezo has worked in the biotech/pharmaceutical industry for over 25 years with a focus on the discovery innovative therapeutics. Dr. Adam Mezo is currently Vice President, Research, Peptides and Bioconjugates at Neurocrine Biosciences, Inc in San Diego. In his current role at Neurocrine, he leads a team focused on the discovery of novel peptide, oligonucleotide and related antibody conjugate therapeutics for a range of unmet medical needs. Prior to this role, he led teams of chemists, biochemists and drug hunters at the Ferring Research Institute, Eli Lilly, Biogen Idec and Syntonix. He has worked in various therapeutics areas, including metabolic disease, hemophilia, immunology, neuroscience and reproductive and women’s health. Dr. Mezo has over 50 published manuscripts and conference presentations, along with over 20 issued US patents. He received his undergraduate degree in chemistry from Queen’s University (Canada), PhD from the University of British Columbia in organic chemistry and performed postdoctoral work at the Massachusetts Institute of Technology in the field of bioorganic chemistry.

Secretary

Bryan Fuchs, Ph.D.
Head Ferring Ventures, San Diego
Board Member

Treasurer

Adrienne Day, Ph.D.
President, Blue Gum Advisors
Independent Board Member